welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy

key information

study id #: NCT03039686

condition: Duchenne Muscular Dystrophy

status: terminated


This is a multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of two different weekly doses of RO7239361 in ambulatory boys with Duchenne Muscular Dystrophy (DMD).

intervention: RO7239361, Placebo for RO7239361

mechanism of action: Anti-myostatin adnectin to promote muscle growth

results: https://clinicaltrials.gov/ct2/show/results/NCT03039686

last updated: May 28, 2020